”米国民では、2型糖尿病検診は30歳と45歳スタートし、3-5年毎が、もっともコスト効果的


Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis
The Lancet, Early Online Publication, 30 March 2010
doi:10.1016/S0140-6736(09)62162-0Cite or Link Using DOI


日本でまともになされることがないQALY研究

simulated screening strategies

*No screening (control)
*Screen the entire population for type 2 diabetes starting at age 30 years. For those not diagnosed, repeat screening every 3 years up to age 75 years (30 years, every 3 years)
*Start screening at age 45 years and repeat every year up to age 75 years (45 years, every year)
*Start screening at age 45 years and repeat every 3 years up to age 75 years (45 years, every 3 years)
*Start screening at age 45 years and repeat every 5 years up to age 75 years (45 years, every 5 years)
*Start screening at age 60 years and repeat every 3 years up to age 75 years (60 years, every 3 years)
*Screen only when the person's blood pressure is greater than 140/90 mm Hg. Repeat screening every year at the corresponding visit for blood pressure monitoring, up to age 75 years (hypertension diagnosis, every year)
*Screen only when the person's blood pressure is greater than 135/80 mm Hg. Repeat screening every 5 years at the corresponding visit for blood pressure monitoring, up to age 75 years (hypertension diagnosis, every 5 years)
*Start screening at age 30 years and repeat every 6 months until age 75 years (maximum screening)



a0007242_1111190.gif


各検診群での50歳をCOSまでの2型糖尿病診断推定比率



a0007242_11020100.gif


50歳までの検診QALYあたりの推定費用




QALY無視の日本の検診研究は、ことごとくクズ 

・・・確信が深まってる

by internalmedicine | 2010-03-30 11:09 | 糖尿病・肥満  

<< コンシェルジュ医療 こうもり同士の衝突防止機能 >>